RxDoctor Payments DataLook up a doctor →

Karmen Clark, PA

Physician Assistant · Ocean Springs, MSNPI 1619035029

Payments from drug & device makers

$49,365in general payments, 2019–2025

Across 1,311 payments — averaging $37.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$25K
  • Amgen$6K
  • Acadia Pharmaceuticals Inc$2K
  • AstraZeneca$1K
  • UCB, Inc.$1K
  • EMD Serono, Inc.$1K
  • plus $13K from 51 others

What the payments were for

  • Consulting fees$1,1002%
  • Speaking & faculty fees$22,94446%
  • Travel & lodging$1,7063%
  • Food & beverage$23,45248%
  • Education$1630%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)262$24,612
Amgen(2 entities)80$5,727
Acadia Pharmaceuticals Inc94$2,440
AstraZeneca(2 entities)59$1,312
UCB, Inc.77$1,292
EMD Serono, Inc.45$1,195
SK Life Science, Inc.61$1,173
Novartis69$1,172
Pfizer64$876
Biogen51$853
Genentech USA, Inc.38$779
Neurocrine Biosciences, Inc.33$685
Lundbeck LLC25$623
Eisai Inc.28$563
Johnson & Johnson(2 entities)20$509
Argenx US, Inc.28$505
Teva Pharmaceuticals USA, Inc.34$505
Lilly USA, LLC30$469
Jazz Pharmaceuticals Inc.12$380
Bristol Myers Squibb20$350
Biohaven Pharmaceutical Holding Company Ltd.15$235
Merz Pharmaceuticals, LLC9$211
Sanofi9$206
Mallinckrodt Hospital Products Inc.7$177
Sunovion Pharmaceuticals Inc.14$169
Otsuka America Pharmaceutical, Inc.9$162
ANI Pharmaceuticals, Inc.8$159
Takeda Pharmaceuticals U.S.A., Inc.7$151
TG Therapeutics, Inc.7$141
Banner Life Sciences, LLC9$139
Boston Scientific2$138
Neurelis, Inc.9$134
Supernus Pharmaceuticals, Inc.10$117
CSL Behring6$114
Adamas Pharmaceuticals, Inc.6$112
Vanda Pharmaceuticals Inc.5$102
Amylyx Pharmaceuticals, Inc.4$93
Ipsen Biopharmaceuticals, Inc3$89
Upsher-smith Laboratories LLC5$85
Avanir Pharmaceuticals, Inc.6$79
Tanabe Pharma America, Inc.5$71
Arbor Pharmaceuticals, Inc.5$65
Amneal Pharmaceuticals LLC3$53
MDD US Operations, LLC3$46
Novo Nordisk1$38
Revance Therapeutics, Inc.2$37
Kyowa Kirin, Inc.2$28
Genentech, Inc.1$25
Alnylam Pharmaceuticals Inc.1$25
Biohaven Pharmaceuticals, Inc.1$25
Life Molecular Imaging Ltd1$23
Cycle Pharmaceuticals Inc1$20
Axsome Therapeutics, Inc.1$18
Collegium Pharmaceutical, Inc.1$16
Sumitomo Pharma America, Inc.1$15
GE HealthCare1$14
Acorda Therapeutics, Inc1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$49,365 in reported general payments places this provider in the 95th percentile of 278 physician assistant providers in Mississippi.

See all physician assistant providers in Mississippi

Medicare billing

Part B allowed, 2024
$29,422
Medicare patients
249
Services billed
372

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RebifInterferon Beta-1a/Albumin12$130,995
IngrezzaValbenazine Tosylate12$91,143
Nurtec OdtRimegepant Sulfate38$62,625
UbrelvyUbrogepant28$41,622
Aimovig AutoinjectorErenumab-Aooe43$40,498
NuedextaDextromethorphan Hbr/Quinidine23$33,619
KeppraLevetiracetam16$18,188
Emgality PenGalcanezumab-Gnlm25$17,989
RytaryCarbidopa/Levodopa12$17,746
Lacosamide122$7,698
Gabapentin361$7,356
Pregabalin148$6,735
Buprenorphine14$6,212
Levetiracetam187$5,035
Levetiracetam ErLevetiracetam88$4,942

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
EMD Serono, Inc.Rebif$1,195$130,99512 claims
Neurocrine Biosciences, Inc.Ingrezza$685$91,14312 claims
PfizerNurtec Odt$876$62,62538 claims
AbbVieUbrelvy$24,612$41,62228 claims
Avanir Pharmaceuticals, Inc.Nuedexta$79$33,61923 claims
Amneal Pharmaceuticals LLCRytary, Pyridostigmine Bromide$53$18,94632 claims
Upsher-smith Laboratories LLCTopiramate$85$1,729123 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 278 physician assistant providers in Mississippi.

Other physician assistant in Ocean Springs

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →